And now your entry for “least interesting news of the day: The Cubs have acquire lefty Hunter Cervenka from Boston as the player to be named later in the Marlon Byrd deal.
I’ve never heard of Cervenka. Guessing most people not related to him haven’t either. Heck, there are probably even some Cervenka cousins who are like “Hunter … is that aunt Mary’s son? I thought he played lacrosse.”
In any event. Cervenka is 22. He has a 5.97 ERA in four minor league season. This year he was 0-3 with 8.04 ERA in the Sally League. And if he turns into the next Pedro Martinez, won’t this post be funny?
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.